Skip to main content

HDC Raises Net from Stock Sale to $2.6M

NEW YORK (GenomeWeb News) - Health Discovery Corporation said today it has received more than $450,000 in additional common equity to add to $2.1 million it received last month in a common stock sale.
 
The company said today it has raised a total of $2.55 million in recent investments. Including $2.1 million in existing secured debt it converted into common or preferred stock, it has increased its coffers to $4.7 million.
 
The company said last month it plans to use the new capital to “focus on executing a business plan that features more biomarker discoveries, licensing and development opportunities, and continued enhancement and protection of our valuable patent estate.”
 
“We now have the financial staying power to fully exploit many of our opportunities,” said HDC’s CEO, Stephen Barnhill.
The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.